Write For Us

Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval

Sponsored Post Vitamin D2 Canada Persia
64 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin. The Drug Controller General of India today gave the go-ahead for the Phase-III trials. The trials will be conducted at nine locations in the country.

About NDTV: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Koo: https://www.kooapp.com/profile/ndtv
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps: http://www.ndtv.com/page/apps

#CoronavirusVaccine #BharatBiotech #NasalBooster
Category
Asia
Tags
NDTV 24x7, Bharat Biotech gets approval, intranasal booster dose
Sign in or sign up to post comments.
Be the first to comment